Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
GRBK compared with COYA: revenue, margins and what each company keeps, and the suppliers and customers both name
GRBK
Green Brick Partners, Inc.
Change
Mkt cap
Revenue
Revenue
COYA
Coya Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
GRBK
Green Brick Partners, Inc.
vs
COYA
Coya Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
GRBK
0 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±9.0%
▼
−0.62%
×0.07
Q2 FY26
±6.7%
▼
−1.96%
×0.30
Q1 FY26
±9.6%
▲
+4.39%
×0.46
Q3 FY25
±8.3%
▲
+2.55%
×0.30
COYA
1 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±51.6%
▲
+3.45%
×0.07
= implied
GRBK realized, solid
COYA realized, hatched
One scale, both sides: full bar = 52%
× = |realized| ÷ implied
Source: market data
GRBK
Green Brick Partners, Inc.
Change
63.17
· pre 63.31
· delayed
Mkt cap
$2.7B
Revenue
$448M
Q3 FY26
Revenue
$2.0B
FY25
COYA
Coya Therapeutics, Inc.
Change
3.25
· pre 3.25
· delayed
Pre-market
Nov 2 '26
delayed
Mkt cap
$11.0M
Revenue
$243,745
Q2 FY26
Revenue
$8M
FY25
vs
Compare
Pre-market
Nov 2 '26
delayed
GRBK
Green Brick Partners, Inc.
vs
COYA
Coya Therapeutics, Inc.
63.17
pre 63.31
delayed
Price
3.25
pre 3.25
delayed
$2.7B
Mkt cap
$11.0M
Q3 FY26
$448M
Revenue
$243,745
Q2 FY26
FY25
$2.0B
Revenue
$8M
FY25
Change
Change
GRBK
63.17
vs
COYA
3.25
Pre-market
Nov 2 '26
delayed